Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis

ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS

1994 • 2,556 citations

Bone density at various sites for prediction of hip fractures

1993 • 2,431 citations

Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women

1991 • 1,113 citations

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

1991 • 1,013 citations

Long-term fracture prediction by bone mineral assessed at different skeletal sites

1993 • 869 citations

EPIDEMIOLOGY OF OSTEOPOROSIS

2005 • 499 citations

A Model of Lifetime Osteoporosis Impact

1991 • 447 citations

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

1992 • 443 citations

Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease

1990 • 431 citations

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.

1993 • 402 citations

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats

1991 • 375 citations

Predisposition to Atherosclerosis in the Head, Heart, and Legs

1972 • 339 citations

The bone-remodeling transient: Implications for the interpretation of clinical studies of bone mass change

1994 • 287 citations

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

1990 • 280 citations

Estrogen treatment of patients with established postmenopausal osteoporosis

1991 • 256 citations

Uterine activity in patients with cervical cerclage.

1990 • 205 citations

Design of the Fracture Intervention Trial

1993 • 177 citations

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women.

1993 • 169 citations

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

1989 • 148 citations

Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.

1994 • 133 citations

Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats

1992 • 124 citations

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis

1994 • 110 citations

The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons

1992 • 103 citations

Estrogen treatment of patients with established postmenopausal osteoporosis

1991 • 100 citations

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women

1993 • 99 citations

A model of lifetime osteoporosis impact

1991 • 86 citations

Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study

1972 • 78 citations

Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin

1993 • 64 citations

Risks and Benefits of Replacement Estrogen

1992 • 56 citations

Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.

1993 • 54 citations

Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis

1994 • 53 citations

Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.

1993 • 31 citations

Nasal salmon calcitonin in osteoporosis

1994 • 19 citations

Comparison of the therapeutic potencies of two bisphosphonates

1992 • 8 citations

Deleted Work

1955 • 0 citations